Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (17 quarters reported)
$64.1M in Q4 2021 → $45.8K now. Hover for any quarter.
As reported for the quarter ended December 31, 2025. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| RH Rafael Hldgs Inc | 100.0% | Unchanged | 38,784 | $45.8K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Figma Inc | Exited | −1,857,845 | −$96.4M | — |
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Figma Inc | New | +1,857,845 | +$96.4M | 99.9% |
quarter ended June 30, 2025 · filed August 14, 2025
No position changes this quarter.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| RH Rafael Hldgs Inc | New | +38,784 | +$72.5K | 100.0% |
| Cyclo Therapeutics Inc | Exited | −110,023 | −$64.9K | — |
quarter ended December 31, 2024 · filed February 14, 2025
No position changes this quarter.
quarter ended September 30, 2024 · filed February 14, 2025
No position changes this quarter.
quarter ended June 30, 2024 · filed August 14, 2024
quarter ended March 31, 2024 · filed May 15, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Roivant Sciences Ltd | Exited | −1,119,489 | −$12.6M | — |
| Snap Inc | New | +9,050 | +$104K | 39.3% |
| Nova Ltd | New | +4,142 | +$7.33K | 2.8% |
Loading...
